Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB0,00
PKN37,7437,85-2,35
Msft-4,96
Nokia3,42153,463-3,05
IBM-3,54
Daimler AG44,1544,165-5,98
PFE-5,29
29.10.2020 1:04:00
Indexy online
AD Index online
select
AD Index online
 

  • 28.10.2020
PharmAust (Frankfurt)
Závěr k 28.10.2020 Změna (%) Změna (EUR) Objem obchodů (EUR)
0,069 0,00 0,00 1 400
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 29.10.2020
Popis společnosti
Obecné informace
Název společnostiPharmAust Limited
TickerPAA
Kmenové akcie:Fully Paid Ord. Shrs
RICPAA.AX
ISINAU000000PAA1
Poslední známé roční výsledky30.06.2020
Poslední známé čtvrtletní výsledky30.06.2020
Počet zaměstnanců k 30.06.2005 52
Akcie v oběhu k 30.06.2020 302 021 053
MěnaAUD
Kontaktní informace
UliceU 39 1 Freshwater Pde
MěstoNEDLANDS
PSČ6010
ZeměAustralia
Kontatní osoba 
Funkce kontaktní osoby 
Telefon61 863 640 899
Fax61894676111

Business Summary: Pharmaust Limited is a drug discovery and development company. The principal activities of the Company are to develop its own drug discovery intellectual property, namely approximately three platforms for the treatment of different types of cancers in humans and animals, as well as providing specialized medicinal and synthetic chemistry services on a contract basis to clients. The Company's segments are Corporate and Pharmaceutical. The Pharmaceutical segment provides products and services in synthetic and medicinal chemistry to the drug discovery and pharmaceutical industries. The Corporate segment covers all the corporate overhead expenses. Its subsidiaries include Pitney Pharmaceuticals Pty Ltd, which is engaged in business of developing therapeutic cancer products, and Epichem Pty Ltd, which offers a range of rare and hard to find pharmaceutical impurities, degradants and metabolites of active ingredients and excipients, particularly for over-the-counter and generic drugs.
Financial Summary: BRIEF: For the fiscal year ended 30 June 2020, PharmAust Limited revenues decreased 6% to A$4.1M. Net loss decreased 12% to A$1.4M. Revenues reflect Revenue decrease of 13% to A$3.2M. Lower net loss reflects Research and development expenses decrease of 42% to A$605K (expense), Administration expenses decrease of 19% to A$1.1M (expense).
Odvětvová klasifikace
TRBC2012Pharmaceuticals - NEC
RBSS2004Pharmaceuticals - Diversified
MGINDUSTRYBiotechnology & Drugs
MGSECTORHealthcare
NAICS1997Pharmaceutical Preparation Manufacturing
NAICS1997Crude Petroleum and Natural Gas Extraction
NAICS1997Research and Development in the Physical, Engineering, and Life Sciences
NAICS1997Offices of Other Holding Companies
SICPharmaceutical Preparations
SICCrude Petroleum And Natural Gas
SICCommercial Physical Research
SICHolding Companies, Nec



  • Poslední aktualizace: 29.10.2020
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Chief Executive OfficerMartine Keenan-10.04.201810.04.2018
Executive DirectorRobert Bishop-29.10.201329.10.2013
Director of Epichem Pty LtdJohn Horton-
Director of Epichem Pty LtdColette Sims-
Company Secretary, Non-Executive Independent DirectorSam Wright-01.10.2008